ENTITY
J.B. Chemicals & Pharmaceuticals

J.B. Chemicals & Pharmaceuticals (JBCP IN)

28
Analysis
Health CareIndia
J.B. Chemicals & Pharmaceuticals Ltd. manufactures pharmaceuticals, chemicals and agro-based products. The Group's products include metrogyl, rantac (a ranitidine-based formula), and nicardia, a cardiac care medicine. The Company has an agreement with Justesa Imagen, to manufacture and market diagnostics under the "Trazograf" brand name.
more
Refresh
05 Jul 2020 16:00

J.B.Chemicals (JBCP IN): Partial Tender Offer by KKR

The Promoters of J.B. Chemicals & Pharma (JBCP IN)announced on 3rd July they had signed an SPA with KKR & Co Inc (KKR US) to sell up to 54%...

Share
07 Dec 2018 20:49

JB Chemicals - 2QFY19 – No Significant Surprises; On Track for Continuing Growth

J.B. Chemicals & Pharma (JBCP IN) 2QFY19 results were in line with our estimates. The revenues were Rs 4,043 mn, 1% higher than our estimates...

Logo
451 Views
Share
13 Oct 2018 19:39

Coverage Universe 2QFY19E Earnings Preview

The 2QFY19E earnings season carries huge importance as the FY19 is turning out to be a year of sharp volatility in performance across all the...

Logo
413 Views
Share
20 Sep 2018 20:16

JB Chemicals Annual Report FY18: Ready for Indian Dosage Driven Growth

We reviewed the FY18 Annual Report of J.B. Chemicals & Pharma (JBCP IN) (JBCPL). The report highlights that its revenues suffered because of...

Logo
397 Views
Share
17 Aug 2018 20:05

JB Chemicals:1QFY19 Result: India Business Building Momentum as Expected

J.B. Chemicals & Pharma (JBCP IN) (JBCPL) reported strong 1QFY19 results with a growth of 29% YoY in revenues to Rs. 3659 mn. The growth was...

Logo
395 Views
Share
x